BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26725100)

  • 1. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
    Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
    J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
    J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection.
    Vuong DA; Rades D; van Eck AT; Horstmann GA; Busse R
    Clin Neurol Neurosurg; 2013 Mar; 115(3):276-84. PubMed ID: 22705458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families.
    Vuong DA; Rades D; Le AN; Busse R
    World Neurosurg; 2012 Feb; 77(2):321-8. PubMed ID: 22120377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases.
    Lal LS; Byfield SD; Chang EL; Franzini L; Miller LA; Arbuckle R; Reasonda L; Feng C; Adamus A; Swint JM
    Am J Clin Oncol; 2012 Feb; 35(1):45-50. PubMed ID: 21293245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
    Kim H; Rajagopalan MS; Beriwal S; Smith KJ
    Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.
    Wernicke AG; Lazow SP; Taube S; Yondorf MZ; Kovanlikaya I; Nori D; Christos P; Boockvar JA; Pannullo S; Stieg PE; Schwartz TH
    Oper Neurosurg (Hagerstown); 2016 Mar; 12(1):49-60. PubMed ID: 27774500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
    Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
    J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
    Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
    J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors.
    Rutigliano MJ; Lunsford LD; Kondziolka D; Strauss MJ; Khanna V; Green M
    Neurosurgery; 1995 Sep; 37(3):445-53; discussion 453-5. PubMed ID: 7501109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases.
    Savitz ST; Chen RC; Sher DJ
    Cancer; 2015 Dec; 121(23):4231-9. PubMed ID: 26372146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases.
    Mehta M; Noyes W; Craig B; Lamond J; Auchter R; French M; Johnson M; Levin A; Badie B; Robbins I; Kinsella T
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):445-54. PubMed ID: 9308949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review.
    Lester-Coll NH; Sher DJ
    Curr Oncol Rep; 2017 Jun; 19(6):41. PubMed ID: 28421482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.
    Parashar B; Port J; Arora S; Christos P; Trichter S; Nori D; Wernicke AG
    Brachytherapy; 2015; 14(5):648-54. PubMed ID: 25998071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.